The US Food and Drug Administration allowed marketing of a new tissue expander system for soft tissue expansion in two-stage breast reconstruction following mastectomy and in the treatment of ...
LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global breast tissue expanders market and the market is poised to grow by USD 189.74 million during 2019-2023, progressing at a CAGR of over ...
The FDA has approved AeroForm, a balloon-like wireless tissue expander, for patients who choose to have reconstructive surgery following a mastectomy or for those with underdeveloped breasts and soft ...
DETROIT - Henry Ford Cancer Institute is the first in Michigan to offer a needle-free, patient-controlled tissue expansion system for women undergoing breast reconstruction after mastectomy. The ...
The US Food and Drug Administration (FDA) has cleared for marketing a novel tissue expander that uses controlled carbon dioxide inflation operated by patients themselves in preparation for a permanent ...
Distinctive lipid profiles of human breast cancer and adjacent normal tissues by desorption electrospray ionization mass spectrometry imaging. This is an ASCO Meeting Abstract from the 2013 ASCO ...
Flora is the only magnet-free and MR Conditional tissue expander cleared for the U.S. market. NEW YORK--(BUSINESS WIRE)-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology ...
Postmastectomy radiation for stage ll breast cancer patients with T1/T2 lesions. This is an ASCO Meeting Abstract from the 2012 Breast Cancer Symposium. This abstract does not include a full text ...
Objective. The rate of postmastectomy tissue expander (TE) infection remains excessively high, ranging between 2% and 24%. We hypothesized that current perioperative antimicrobial regimens utilized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback